A streamlined system for species diagnosis in Caenorhabditis (Nematoda: Rhabditidae) with name designations for 15 distinct biological species

PLoS One. 2014 Apr 11;9(4):e94723. doi: 10.1371/journal.pone.0094723. eCollection 2014.

Abstract

The rapid pace of species discovery outstrips the rate of species description in many taxa. This problem is especially acute for Caenorhabditis nematodes, where the naming of distinct species would greatly improve their visibility and usage for biological research, given the thousands of scientists studying Caenorhabditis. Species description and naming has been hampered in Caenorhabditis, in part due to the presence of morphologically cryptic species despite complete biological reproductive isolation and often enormous molecular divergence. With the aim of expediting species designations, here we propose and apply a revised framework for species diagnosis and description in this group. Our solution prioritizes reproductive isolation over traditional morphological characters as the key feature in delineating and diagnosing new species, reflecting both practical considerations and conceptual justifications. DNA sequence divergence criteria help prioritize crosses for establishing patterns of reproductive isolation among the many species of Caenorhabditis known to science, such as with the ribosomal internal transcribed spacer-2 (ITS2) DNA barcode. By adopting this approach, we provide new species name designations for 15 distinct biological species, thus increasing the number of named Caenorhabditis species in laboratory culture by nearly 3-fold. We anticipate that the improved accessibility of these species to the research community will expand the opportunities for study and accelerate our understanding of diverse biological phenomena.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Caenorhabditis / classification*
  • Caenorhabditis / genetics*
  • Crosses, Genetic
  • DNA, Intergenic
  • Evolution, Molecular
  • Phylogeny
  • Reproductive Isolation

Substances

  • DNA, Intergenic

Grants and funding

ADC is supported by funds from a Canada Research Chair, the Natural Sciences and Engineering Research Council of Canada, and the National Institutes of Health. MAF is supported by funds from the Ecole Normale Supérieure, the CNRS, the Agence Nationale pour la Recherche and a Coup d'Elan de la Fondation Bettencourt-Schueller. CB is supported by funds from the CNRS, the Agence Nationale pour la Recherche, and the Fondation Schlumberger pour l'Education et la Recherche. The funders had nor role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.